RnDCircle Logo
권정훈 연구실
경북대학교 수의학과
권정훈 교수
기본 정보
연구 분야
프로젝트
발행물
구성원

권정훈 연구실

경북대학교 수의학과 권정훈 교수

권정훈 연구실은 수의미생물학을 기반으로 조류인플루엔자, 동물 코로나바이러스, PEDV, PRRSV 등 주요 동물바이러스의 진화와 전파를 유전체 수준에서 분석하고, 차세대 염기서열 분석과 분자역학 기법을 활용한 감시체계 구축, 신속 진단기술 개발, 그리고 현장 적용이 가능한 약독화·사가·다가 백신의 개발 및 산업화를 함께 추진하는 수의바이러스 연구를 수행하고 있다.

대표 연구 분야
연구 영역 전체보기
고병원성 조류인플루엔자 바이러스의 진화와 분자역학 thumbnail
고병원성 조류인플루엔자 바이러스의 진화와 분자역학
주요 논문
3
논문 전체보기
1
article
|
인용수 26
·
2024
Evolution and Spread of Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus in Wild Birds, South Korea, 2022–2023
Ye-Ram Seo, Andrew Y. Cho, Young‐Jae Si, Song‐I Lee, Dong‐Ju Kim, Hyesung Jeong, Jung‐Hoon Kwon, Chang‐Seon Song, Dong‐Hun Lee
IF 6.6
Emerging infectious diseases
During October 2022-March 2023, highly pathogenic avian influenza (HPAI) A(H5N1) clade 2.3.4.4b virus caused outbreaks in South Korea, including 174 cases in wild birds. To understand the origin and role of wild birds in the evolution and spread of HPAI viruses, we sequenced 113 HPAI isolates from wild birds and performed phylogenetic analysis. We identified 16 different genotypes, indicating extensive genetic reassortment with viruses in wild birds. Phylodynamic analysis showed that the viruses were most likely introduced to the southern Gyeonggi-do/northern Chungcheongnam-do area through whooper swans (Cygnus cygnus) and spread southward. Cross-species transmission occurred between various wild bird species, including waterfowl and raptors, resulting in the persistence of HPAI in wild bird populations and further geographic spread as these birds migrated throughout South Korea. Enhanced genomic surveillance was an integral part of the HPAI outbreak response, aiding in timely understanding of the origin, evolution, and spread of the virus.
https://doi.org/10.3201/eid3002.231274
Reassortment
Influenza A virus subtype H5N1
Waterfowl
Clade
Outbreak
Biology
Phylogenetic tree
Highly pathogenic
Virology
Virus
2
article
|
gold
·
인용수 2
·
2023
Phylodynamic analysis revealed that human mobility and vaccination were correlated to the local spread of SARS-CoV-2 in Republic of Korea
Sangyi Lee, Dongwook Lee, Jeongmin Kim, Da-Won Kim, Jiyun Kim, Jeong-Ah Kim, Il‐Hwan Kim, Jee Eun Rhee, Kyung‐Duk Min, Sung‐Il Cho, Eun‐Jin Kim, Jung‐Hoon Kwon
IF 7.5
Emerging Microbes & Infections
Following the global emergence of the SARS-CoV-2 Alpha variant of concern (VOC) in 2020, the Delta variant triggered another wave in 2021. The AY.69 lineage, a Delta VOC, was particularly prevalent in Republic of Korea (South Korea) from May 2021 to January 2022, despite the synchronized implementation of vaccination programmes and non-pharmaceutical interventions (NPIs) such as social distancing. In this study, we used phylogeographic analysis combined with a generalized linear model (GLM) to examine the impact of human movement and vaccination on viral transmission. Our findings indicated that transmission primarily originated in South Korea's metropolitan areas, and a positive correlation was observed between total human mobility (tracked by GPS on mobile phones and estimated through credit card consumption) and viral spread. The phylodynamic analysis further revealed that non-vaccinated individuals were the primary transmitters of the virus during the study period, even though vaccination programmes had commenced three months prior to the AY.69 outbreak. Our study emphasizes the need to focus on controlling SARS-CoV-2 transmission in metropolitan regions and among unvaccinated populations. Furthermore, the positive correlation between mobility data and viral dissemination could contribute to the development of more accurate predictive models for local spread of pandemics.
https://doi.org/10.1080/22221751.2023.2228934
Vaccination
Transmission (telecommunications)
Pandemic
Metropolitan area
Demography
Geography
Psychological intervention
Outbreak
Virology
Environmental health
3
article
|
gold
·
인용수 37
·
2023
Diverse infectivity, transmissibility, and pathobiology of clade 2.3.4.4 H5Nx highly pathogenic avian influenza viruses in chickens
Jung‐Hoon Kwon, Kateri Bertran, Dong‐Hun Lee, Miriã F. Criado, Lindsay Killmaster, Mary J. Pantin‐Jackwood, David E. Swayne
IF 7.5
Emerging Microbes & Infections
Clade 2.3.4.4 Eurasian lineage H5Nx highly pathogenic avian influenza virus (HPAIV) has become the globally dominant clade and caused global outbreaks since 2014. The clade 2.3.4.4 viruses have evolved into eight hemagglutinin subgroups (2.3.4.4a-h). In this study, we evaluated the infectivity, pathobiology, and transmissibility of seven clade 2.3.4.4 viruses (two 2.3.4.4a, two 2.3.4.4b, one 2.3.4.4c and two 2.3.4.4e) in chickens. The two clade 2.3.4.4e viruses caused 100% mortality and transmissibility in chickens. However, clade 2.3.4.4a and c viruses showed 80-90% mortality and 67% transmissibility. Clade 2.3.4.4b viruses showed 100% mortality, but no transmission to co-housed chickens was observed based on lack of seroconversion. All the infected chickens died showing systemic infection, irrespective of subgroup. The results highlight that all the clade 2.3.4.4 HPAIVs used in this study caused high mortality in infected chickens, but the transmissibility of the viruses in chickens was variable in contrast to that of previous Eurasian-lineage H5N1 HPAIVs. Changes in the pathogenicity and transmissibility of clade 2.3.4.4 HPAIVs warrant careful monitoring of the viruses to establish effective control strategies.
https://doi.org/10.1080/22221751.2023.2218945
Clade
Transmissibility (structural dynamics)
Biology
Infectivity
Virology
Influenza A virus subtype H5N1
Virus
Lineage (genetic)
Outbreak
Seroconversion
정부 과제
11
과제 전체보기
1
2025년 3월-2027년 12월
|633,334,000
최근 국내 발생 돼지유행성설사병 유행주 및 변이주 방어에 최적화 된 고효능 약독화 생백신 및 복합 사독백신 개발 및 상용화
(1) 최신 유행 PEDV 분리주를 활용한 생독백신 제품화 (2) PEDV 최신 유행주·변이주 및 고면역 어주번트를 포함하는 다가 사독백신 제품화
돼지유행성설사바이러스
생독백신
사독백신
면역증강제
2
2025년 3월-2027년 12월
|460,840,000
국내 고병원성 PRRSV 변이주 예방을 위한 다가백신 개발 및 산업화
목표 1. 국내 고위험성 PRRSV 유전형들에 대한 고효능 키메라 약독화 백신 개발 및 제품화목표 2. 국내 고위험성 PRRSV 유전형들에 대한 고효능 사독 다가백신 (3가) 개발 및 제품화
돼지생식기호흡기증후군
약독화백신
면역증강제
사독 다가백신
제품화
3
2025년 3월-2027년 12월
|475,000,000
최근 국내 발생 돼지유행성설사병 유행주 및 변이주 방어에 최적화 된 고효능 약독화 생백신 및 복합 사독백신 개발 및 상용화
(1) 최신 유행 PEDV 분리주를 활용한 생독백신 제품화 (2) PEDV 최신 유행주·변이주 및 고면역 어주번트를 포함하는 다가 사독백신 제품화
돼지유행성설사바이러스
생독백신
사독백신
면역증강제